ARWR: Arrowhead Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ARWR: Arrowhead Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,061.27
Enterprise Value ($M) 2,504.29
Book Value ($M) 684.23
Book Value / Share 4.96
Price / Book 3.01
NCAV ($M) -703.56
NCAV / Share -5.10
Price / NCAV -2.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.10
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 0.84
Current Ratio 0.84

Balance Sheet (mrq) ($M)
Current Assets 185.71
Assets 1,573.50
Liabilities 889.27
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.55
Operating Income -601.08
Net Income -599.49
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -462.85
Cash from Investing -420.07
Cash from Financing 870.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13G State Street Corp 5.10 16.34
04-23 13G/A BlackRock, Inc. 13.80 42.92
02-14 13D Sarepta Therapeutics, Inc. 9.50
02-14 13G/A Avoro Capital Advisors LLC 9.60 35.32

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 534,872 2,094,581 25.54
2025-05-13 1,106,619 4,049,397 27.33
2025-05-12 316,571 1,614,632 19.61
2025-05-09 162,520 876,648 18.54

(click for more detail)

Similar Companies
APLS – Apellis Pharmaceuticals, Inc. ARQT – Arcutis Biotherapeutics, Inc.
ARVN – Arvinas, Inc. ASMB – Assembly Biosciences, Inc.
ATRA – Atara Biotherapeutics, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Arrowhead Pharmaceuticals